804 related articles for article (PubMed ID: 26199017)
21. Chlorhexidine-silver sulfadiazine-impregnated venous catheters are efficient even at subclavian sites without tracheostomy.
Lorente L; Lecuona M; Jiménez A; Cabrera J; Santacreu R; Lorenzo L; Raja L; Mora ML
Am J Infect Control; 2016 Dec; 44(12):1526-1529. PubMed ID: 27378009
[TBL] [Abstract][Full Text] [Related]
22. Emergency Department Central Line-associated Bloodstream Infections (CLABSI) Incidence in the Era of Prevention Practices.
Theodoro D; Olsen MA; Warren DK; McMullen KM; Asaro P; Henderson A; Tozier M; Fraser V
Acad Emerg Med; 2015 Sep; 22(9):1048-55. PubMed ID: 26336036
[TBL] [Abstract][Full Text] [Related]
23. Rifampicin-impregnated central venous catheters: a meta-analysis of randomized controlled trials.
Falagas ME; Fragoulis K; Bliziotis IA; Chatzinikolaou I
J Antimicrob Chemother; 2007 Mar; 59(3):359-69. PubMed ID: 17255143
[TBL] [Abstract][Full Text] [Related]
24. Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial.
Hanna H; Benjamin R; Chatzinikolaou I; Alakech B; Richardson D; Mansfield P; Dvorak T; Munsell MF; Darouiche R; Kantarjian H; Raad I
J Clin Oncol; 2004 Aug; 22(15):3163-71. PubMed ID: 15284269
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of antiseptic-impregnated catheters on catheter colonization and catheter-related bloodstream infections in patients in an intensive care unit.
Osma S; Kahveci SF; Kaya FN; Akalin H; Ozakin C; Yilmaz E; Kutlay O
J Hosp Infect; 2006 Feb; 62(2):156-62. PubMed ID: 16307824
[TBL] [Abstract][Full Text] [Related]
26. Antimicrobial-impregnated central venous catheters for preventing neonatal bloodstream infection: the PREVAIL RCT.
Gilbert R; Brown M; Faria R; Fraser C; Donohue C; Rainford N; Grosso A; Sinha AK; Dorling J; Gray J; Muller-Pebody B; Harron K; Moitt T; McGuire W; Bojke L; Gamble C; Oddie SJ
Health Technol Assess; 2020 Nov; 24(57):1-190. PubMed ID: 33174528
[TBL] [Abstract][Full Text] [Related]
27. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters.
Fraenkel D; Rickard C; Thomas P; Faoagali J; George N; Ware R
Crit Care Med; 2006 Mar; 34(3):668-75. PubMed ID: 16505651
[TBL] [Abstract][Full Text] [Related]
28. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.
Lai NM; Chaiyakunapruk N; Lai NA; O'Riordan E; Pau WS; Saint S
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD007878. PubMed ID: 26982376
[TBL] [Abstract][Full Text] [Related]
29. Observational trial of antibiotic-coated central venous catheters in critically ill pediatric patients.
Chelliah A; Heydon KH; Zaoutis TE; Rettig SL; Dominguez TE; Lin R; Patil S; Feudtner C; St John KH; Bell LM; Coffin SE
Pediatr Infect Dis J; 2007 Sep; 26(9):816-20. PubMed ID: 17721377
[TBL] [Abstract][Full Text] [Related]
30. Peripherally inserted central catheters are associated with lower risk of bloodstream infection compared with central venous catheters in paediatric intensive care patients: a propensity-adjusted analysis.
Yamaguchi RS; Noritomi DT; Degaspare NV; Muñoz GOC; Porto APM; Costa SF; Ranzani OT
Intensive Care Med; 2017 Aug; 43(8):1097-1104. PubMed ID: 28584925
[TBL] [Abstract][Full Text] [Related]
31. Novel approach using antimicrobial catheters to improve the management of central line-associated bloodstream infections in cancer patients.
Chaftari AM; Kassis C; El Issa H; Al Wohoush I; Jiang Y; Rangaraj G; Caillouet B; Pravinkumar SE; Hachem RY; Raad II
Cancer; 2011 Jun; 117(11):2551-8. PubMed ID: 24048803
[TBL] [Abstract][Full Text] [Related]
32. Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study.
Arvaniti K; Lathyris D; Clouva-Molyvdas P; Haidich AB; Mouloudi E; Synnefaki E; Koulourida V; Georgopoulos D; Gerogianni N; Nakos G; Matamis D;
Crit Care Med; 2012 Feb; 40(2):420-9. PubMed ID: 21926583
[TBL] [Abstract][Full Text] [Related]
33. Antibiotic-Impregnated Central Venous Catheters Do Not Change Antibiotic Resistance Patterns.
Turnbull IR; Buckman SA; Horn CB; Bochicchio GV; Mazuski JE
Surg Infect (Larchmt); 2018 Jan; 19(1):40-47. PubMed ID: 29028461
[TBL] [Abstract][Full Text] [Related]
34. Antimicrobial-impregnated central venous catheters for prevention of neonatal bloodstream infection (PREVAIL): an open-label, parallel-group, pragmatic, randomised controlled trial.
Gilbert R; Brown M; Rainford N; Donohue C; Fraser C; Sinha A; Dorling J; Gray J; McGuire W; Gamble C; Oddie SJ;
Lancet Child Adolesc Health; 2019 Jun; 3(6):381-390. PubMed ID: 31040096
[TBL] [Abstract][Full Text] [Related]
35. Prevention of transmission of multidrug-resistant organisms during catheter exchange using antimicrobial catheters.
Jamal MA; Rosenblatt J; Jiang Y; Hachem R; Chaftari AM; Raad II
Antimicrob Agents Chemother; 2014 Sep; 58(9):5291-6. PubMed ID: 24957841
[TBL] [Abstract][Full Text] [Related]
36. Impregnated central venous catheters for prevention of bloodstream infection in children (the CATCH trial): a randomised controlled trial.
Gilbert RE; Mok Q; Dwan K; Harron K; Moitt T; Millar M; Ramnarayan P; Tibby SM; Hughes D; Gamble C;
Lancet; 2016 Apr; 387(10029):1732-42. PubMed ID: 26946925
[TBL] [Abstract][Full Text] [Related]
37. Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter.
Jaeger K; Zenz S; Jüttner B; Ruschulte H; Kuse E; Heine J; Piepenbrock S; Ganser A; Karthaus M
Ann Hematol; 2005 Apr; 84(4):258-62. PubMed ID: 15549302
[TBL] [Abstract][Full Text] [Related]
38. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial.
Rupp ME; Lisco SJ; Lipsett PA; Perl TM; Keating K; Civetta JM; Mermel LA; Lee D; Dellinger EP; Donahoe M; Giles D; Pfaller MA; Maki DG; Sherertz R
Ann Intern Med; 2005 Oct; 143(8):570-80. PubMed ID: 16230723
[TBL] [Abstract][Full Text] [Related]
39. A comparative evaluation of antimicrobial coated versus nonantimicrobial coated peripherally inserted central catheters on associated outcomes: A randomized controlled trial.
Storey S; Brown J; Foley A; Newkirk E; Powers J; Barger J; Paige K
Am J Infect Control; 2016 Jun; 44(6):636-41. PubMed ID: 27240799
[TBL] [Abstract][Full Text] [Related]
40. Peripherally inserted central venous catheters in the acute care setting: A safe alternative to high-risk short-term central venous catheters.
Al Raiy B; Fakih MG; Bryan-Nomides N; Hopfner D; Riegel E; Nenninger T; Rey J; Szpunar S; Kale P; Khatib R
Am J Infect Control; 2010 Mar; 38(2):149-53. PubMed ID: 19836854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
